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Fax: 0086-21-55621735; e-mail: liaozhuan@smmu.edu.cn 3 We have read with interest the recent publication of Hegyi and Sahin-Tóth 1 reporting that chronic pancreatitis (CP)-predisposing CPA1 mutations function through the misfolding pathway rather than through loss of CPA1 protein/activity. Herein, we explore an additional insight gleaned from this study beyond those discussed in an accompanying Editorial. 2 .
In the original study reporting the association of CPA1 variants with CP, all unambiguous loss-of-function (LoF) variants (e.g., nonsense mutations) were lumped together with missense mutations that functionally impaired the CPA1 protein. 3 However, unlike missense mutations, unambiguous LoF variants often result in transcripts that contain premature termination codons (PTC) and are thus prone to nonsense-mediated RNA decay (NMD).
NMD detects and degrades PTC-containing transcripts, thereby preventing the accumulation of truncated proteins. 4, 5 This implies that most unambiguous LoF CPA1 variants would not be able to elicit ER stress and hence, in the light of the Hegyi and Sahin-Tóth study, will not predispose to CP. Indeed, the most frequently observed LoF variant, c.79C>T (p.Arg27*), was present at a lower frequency in European CP patients than in controls (Table 1) .
Additionally, we evaluated the pLI score for CPA1 in the Genome Aggregation Database (genomAD; http://gnomad.broadinstitute.org/). The pLI score indicates the probability that a gene is intolerant to heterozygous LoF variants, ranging from 0 (completely tolerated) to 1.0 (extremely intolerant). 6 The pLI score for CPA1 is 0. For the sake of comparison, PRSS1 and SPINK1 have pLI scores of 0 and 0.33 respectively; unambiguous LoF variants in the PRSS1 gene actually protect against CP whereas unambiguous LoF variants in the SPINK1 gene predispose to CP. 7 Of the CPA1 variants so far reported, 8 five may be regarded as unambiguous LoF variants by virtue of their mutation type and location (Table 1) . We surveyed the clinical significance of these five LoF variants 8 . It would appear that only the classification of c.79C>T
(p.Arg27*) as benign is strongly supported by genetic epidemiological data ( figure 1) . We also elucidated the precise splicing consequences of the two splice site mutations (i.e., c.148-1G>A and c.1072+1G>T) in a minigene system (see online supplementary figure S1); both gave rise to transcripts that were prone to NMD. All experimental details are described in online supplementary material, This may help to explain why rare functionally defective CPA1 variants were not found to be associated with CP in a large Chinese cohort study. Combined European data from reference 2 unless otherwise specified. c Detected in a pancreatic cancer patient.
